May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Polypoidal Choroidal Vasculopathy: Clinical Findings and Angiographic Features
Author Affiliations & Notes
  • T. Fiore
    Department of Ophthalmology & Visual Sciences, San Raffaele Hospital, Milan, Italy
  • U. Introini
    Department of Ophthalmology & Visual Sciences, San Raffaele Hospital, Milan, Italy
  • D.J. D'Amico
    Ophthalmology, Massachusetts Eye & Ear Infirmary, Boston, MA, United States
  • R. Brancato
    Ophthalmology, Massachusetts Eye & Ear Infirmary, Boston, MA, United States
  • Footnotes
    Commercial Relationships  T. Fiore, None; U. Introini, None; D.J. D'Amico, None; R. Brancato, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3160. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Fiore, U. Introini, D.J. D'Amico, R. Brancato; Polypoidal Choroidal Vasculopathy: Clinical Findings and Angiographic Features . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3160.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine the clinical and angiographic findings in a retrospective consecutive series of white European patients diagnosed as affected by polypoidal choroidal vasculopathy (PCV), and to explore for possible associations with other retinal diseases. Methods: A retrospective analysis of a consecutive series of 111 eyes of 105 patients affected by PCV was performed in our clinic. Indocyanine green (ICG) angiography, fluorangiography (FA), biomicroscopy and ophthalmic examination were performed, and correlated with clinical history. Results: PCV was found coexisting with no apparent underlying retinal disorders in 33 (29.7%) eyes, with AMD in 50 (45.1%) eyes, with CSC in 22 (19.8%) eyes, and with underlying retinal diseases apart from AMD and CSC in 6 (5.4%) eyes. In eyes affected by CSC, PCV was more commonly located in the macula (p=0.042) and more frequently visible on FA (p=0.001). A higher incidence of females was found in eyes presenting with PCV coexisting with AMD (p=0.052). Conclusions: PCV is a clinical entity that should be suspected in all eyes with retinal blood and exudation of unclear origin regardless sex, race and underlying retinal disorders. ICG is the diagnostic procedure to establish a more accurate diagnosis, although hot spots in PCV must be distinguished from hot spots described in retinal angiomatous proliferation (RAP) and focal occult choroidal neovascularization (CNV).

Keywords: choroid: neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×